CD24 and CD44 expression in Indian breast cancer patients and response to chemotherapy

被引：0
|
作者：
Sonkar, A. A. [1 ]
Miller, J. L. [1 ]
Agarwal, A. A. [1 ]
Singh, K. R. [1 ]
Husain, N. [2 ]
Kushwaha, J. K. [1 ]
机构：
[1] King Georges Med Univ, Surg, Lucknow, Uttar Pradesh, India
[2] RML Inst Med Sci, Pathol, Lucknow, Uttar Pradesh, India
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70309-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P277
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [21] Expression of CD44 and CD24 in primary ductal invasive carcinoma of breast and metastatic lymph nodes
    Gudadze, M.
    Kankava, K.
    Javakhishvili, T.
    Sarishvili, M.
    Burkadze, G.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S242 - S242
  • [22] CANCER STEM CELLS CHARACTERIZATION IN INVASIVE BREAST CARCINOMAS THROUGH CD44, CD24 AND ALDH1 EXPRESSION
    Ricardo, S.
    Vieira, A.
    Milanezi, F.
    Cameselle, J.
    Schmitt, F.
    Paredes, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 28 - 29
  • [23] Clinicopathologic Correlation of CD44 + /CD24 − Expression in Breast Cancer: a Report from Tertiary Care Medical University in India
    Akshay Anand
    Kushagra Gaurav
    Joy L. Miller
    Kul Ranjan Singh
    Manish Kumar Agrawal
    Surender Kumar
    Nuzhat Husain
    Preeti Agarwal
    Apoorva Agarwal
    Abhinav Arun Sonkar
    [J]. Indian Journal of Surgical Oncology, 2023, 14 : 204 - 207
  • [24] Investigation of CD24, CD44, VEGFa and MGMT expression levels in serum samples of glioblastoma patients
    Gonulkirmaz, N.
    Al-Beyati, E. S. M.
    Ozkan, T.
    Yildiz, D. Akcora
    Dilek, Y.
    Dener, E.
    Ugur, H. C.
    Sunguroglu, A.
    [J]. FEBS OPEN BIO, 2022, 12 : 112 - 112
  • [25] Effect of Three Calmodulin Antagonists on Subpopulations of CD44/CD24 Immunophenotypes in Breast Cancer Cell Lines
    Wali, Abdulwahab Noor
    El Shal, Mohammed Farouk
    Alkhatib, Mayson H.
    Damiati, Laila A.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (08) : 1393 - 1398
  • [26] Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
    Jaggupilli, Appalaraju
    Elkord, Eyad
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [27] Correlation of CD44 and CD24 expression with the positive response after neoadjuvant chemotherapy in stage IIIB breast cancer patient at Dr. Saiful Anwar Hospital, Malang, Indonesia
    Budianto, Muhammad Bachtiar
    Isharanto, Artono
    Haris, Andry
    [J]. BALI MEDICAL JOURNAL, 2021, 10 (01) : 99 - 102
  • [28] CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
    Moon, Yong Wha
    An, Hee-Jung
    Koo, Ja Seung
    Kim, Gun Min
    Han, Hyunju
    Park, Seho
    Kim, Seung Il
    Park, Hyung Seok
    Kim, Sewha
    Kim, Seung Ki
    Lee, Seung Ah
    Hwang, Sohyun
    Son, Gun Woo
    Sohn, Joohyuk
    [J]. ONCOTARGET, 2018, 9 (02) : 2622 - 2630
  • [29] Selective localization of CD44 expression as a predictor of recurrence and response to neoadjuvant chemotherapy in breast cancer patients.
    Ramchandani, NR
    Buxton, MB
    Hylton, NM
    Esserman, LJ
    Bourguignon, LY
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S74 - S74
  • [30] Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
    de Beca, Francisco Ferro
    Caetano, Pedro
    Gerhard, Rene
    Alvarenga, Cesar Augusto
    Gomes, Madalena
    Paredes, Joana
    Schmitt, Fernando
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (03) : 187 - 191
12345